All News

Products containing Delta-8 THC may be leading to an increase in calls to poison control centers, according to a recent study.

A recently published white paper delves into data on market and consumer trends for pre rolls.

A recent study targeting mild to moderate anxiety disorders showed that oral CBD can be a safe, effective treatment option.

As we prepare to publish our full Back to Basics: Soil’s Crucial Role in Cannabis Cultivation interview, let’s revisit some of the tips and insights from our cultivation experts, Adam Jacques, a world-renowned cannabis geneticist and Zacariah L. Hildenbrand, a research Professor at the University of Texas at El Paso.

Voters in North Dakota will see recreational cannabis on the ballot this November.

One study analyzed nearly 100 CBD products to test the accuracy of advertised cannabinoid content.

Cannabis Science and Technology® magazine is seeking contributed manuscripts for our peer-review process and regular feature articles for upcoming 2024/2025 issues.

Researchers sought to provide community-based evidence in the co-use of opioids and cannabis among people who inject drugs.

A new study demonstrates the neuroprotective properties of the supplement N-Acetylcysteine against effects of cannabis exposure in adolescence.

This article, originally published by our sister brand LCGC International, discusses how Connecticut Agricultural Experiment Station scientists recently have been utilizing gas chromatography with flame ionization detection (GC-FID) to measure different components in cannabis hemp samples.

This month’s Healer webinar provided a deep dive into several studies on cannabis for various conditions.

This presentation provided a comprehensive overview of cannabigerol (CBG), highlighting two studies on its effects on anxiety, stress, and pain.

In honor of National CBD Day on August 8 (8/8/24), we compiled eight articles on various aspects of cannabidiol (CBD).

Read three factoids about hemp and its seeds on nutrition, history, and certification.

As reported by our sister publication, Nutritional Outlook, Fresh Hemp Foods, which is owned by Tilray Brands Inc, recently announced its acquisition of US company The Humble Seed.

The majority of comments on the scheduling of cannabis favored change, though several other aspects of cannabis policy remain to be addressed.

The 23rd episode in the monthly webinar series discusses vape manufacturing, consumers, and solutions to health and safety risks.

A recent study released by Cambium Analytica revealed FlackTek™ technology can effectively assist in the solvent purging process for cannabis extracts.

The discussion surrounding intoxicating the manufacture and sale of hemp-derived cannabinoids continues with more proposals and challenges.

Tilray’s Aphria RX obtained a cannabis trading license recently in Germany.

California’s bill creating new restrictions on intoxicating hemp products has prompted responses citing negative impacts on patients and businesses.

In reversal of recent developments, officials in Thailand have signaled that cannabis will not be re-criminalized.

The NCAA Division I Council recently voted to remove cannabinoids from their banned drug class for postseason football and NCAA championships.

A recently published study examined data on thousands of pregnancies, maternal health outcomes, and cannabis use.

Americans for Safe Access, a medical cannabis patient advocacy organization, held a briefing on the final day of the comment period for the proposed rulemaking on cannabis.

This article, originally published by our sister brand Nutritional Outlook, covered updates from the U.S. Food and Drug Administration and Federal Trade Commission on their jointly issued warning letters to five companies for selling copycat food products containing delta-8 THC in violation of the Federal Food Drug and Cosmetic Act.

Cannabis Science and Technology is pleased to announce the addition of Hannia Mendoza-Dickey to its Editorial Advisory Board.

This month’s webinar discussed studies conducted on cannabis and psychedelics for various conditions including anxiety and autism spectrum disorder.

Check out some of our most popular content from the first six months of the year 2024!

This latest episode of the monthly webinar series untangled the various aspects currently facing the US hemp industry.